Merck & Co., Inc. - Stock Analysis

Drug Manufacturers - General
Healthcare

Merck & Co., Inc.

MRK · US · NYSE

114.55

USD

+0.63

(0.55%)

5.42

EPS
21.13

P/E
290B

MARKET CAP
2.65%

DIV YIELD

Ten CAP valuation

Operating Cash Flow

$

Capital Expenditures

$

% for Maintenance

%

Maintenance CapEx

$

Tax Provision

$

Shares Outstanding

#

Owner Earnings

$

Owner Earnings per Share

$

--

Margin Of Safety valuation

Current EPS

$

Future Growth Rate

%

Future PE

Minimum Accepatable Rate Of Return

%

Sticker Price:

--

MOS Price:

--